Qinglin Pei

1.3k total citations
59 papers, 786 citations indexed

About

Qinglin Pei is a scholar working on Pathology and Forensic Medicine, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Qinglin Pei has authored 59 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 16 papers in Neurology and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Qinglin Pei's work include Lymphoma Diagnosis and Treatment (29 papers), Childhood Cancer Survivors' Quality of Life (14 papers) and Acute Lymphoblastic Leukemia research (13 papers). Qinglin Pei is often cited by papers focused on Lymphoma Diagnosis and Treatment (29 papers), Childhood Cancer Survivors' Quality of Life (14 papers) and Acute Lymphoblastic Leukemia research (13 papers). Qinglin Pei collaborates with scholars based in United States, Canada and China. Qinglin Pei's co-authors include Kara M. Kelly, Kathleen M. McCarten, Cindy L. Schwartz, Rizvan Bush, Péter Schmidt, Sharon M. Castellino, Paul M. Jenkins, Corey Williams, Stephen R. Norris and Kristen J. Verhey and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Qinglin Pei

52 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qinglin Pei United States	16	302	217	160	132	127	59	786
Richard Rovin United States	17	136 0.5×	291 1.3×	112 0.7×	33 0.3×	117 0.9×	57	1.1k
Dipayan Mitra United Kingdom	17	219 0.7×	283 1.3×	29 0.2×	108 0.8×	72 0.6×	40	868
Joseph D. Ciacci United States	18	399 1.3×	114 0.5×	31 0.2×	35 0.3×	218 1.7×	62	1.1k
Niveditha Mohan United States	8	164 0.5×	122 0.6×	55 0.3×	26 0.2×	46 0.4×	15	1.0k
Mark Dexter Australia	16	69 0.2×	299 1.4×	44 0.3×	104 0.8×	89 0.7×	55	830
Zohreh Habibi Iran	15	160 0.5×	188 0.9×	36 0.2×	101 0.8×	53 0.4×	91	713
Marilly Palettas United States	16	74 0.2×	66 0.3×	95 0.6×	60 0.5×	97 0.8×	64	633
Liliana Patrucco Argentina	17	687 2.3×	269 1.2×	98 0.6×	18 0.1×	66 0.5×	83	992
Ruediger P. Laubender Germany	21	129 0.4×	123 0.6×	370 2.3×	51 0.4×	62 0.5×	54	947
David H. Harter United States	15	64 0.2×	239 1.1×	42 0.3×	76 0.6×	82 0.6×	50	604

Countries citing papers authored by Qinglin Pei

Since Specialization

Citations

This map shows the geographic impact of Qinglin Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglin Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglin Pei more than expected).

Fields of papers citing papers by Qinglin Pei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglin Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglin Pei. The network helps show where Qinglin Pei may publish in the future.

Co-authorship network of co-authors of Qinglin Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglin Pei. A scholar is included among the top collaborators of Qinglin Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglin Pei. Qinglin Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Yujia, Liping Guo, Xinru Qi, et al.. (2025). Development and evaluation of the recombinant BP26 protein-based C-ELISA for human brucellosis diagnosis. Frontiers in Microbiology. 15. 1516915–1516915. 2 indexed citations

Marks, Lianna J., Yue Wu, Kathleen M. McCarten, et al.. (2025). PET Response and Outcome in Low‐Risk Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1. Pediatric Blood & Cancer. 72(5). e31606–e31606. 1 indexed citations

Xie, Y. G., Liping Guo, Xinru Qi, et al.. (2025). Establishment of an I-ELISA method based on multi-epitope fusion protein for diagnosis of human brucellosis. PLoS neglected tropical diseases. 19(4). e0012995–e0012995.

Pei, Qinglin, et al.. (2025). Once- Versus Twice-Daily Measures of Mothers’ Own Milk Biomarkers: Does It Make a Difference in Research and Practice?. Breastfeeding Medicine. 20(7). 521–527. 1 indexed citations

Ding, Zhen, et al.. (2025). Assessment of smartphone addiction and its relationship with health-promoting lifestyle profile and intuitive eating behavior: a cross-sectional study. Frontiers in Psychiatry. 16. 1682921–1682921.

Williams, AnnaLynn M., Angie Mae Rodday, Qinglin Pei, et al.. (2024). Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children's Oncology Group AHOD 1331 Study. Journal of Clinical Oncology. 42(28). 3330–3338. 4 indexed citations

Heneghan, Mallorie B., Susan K. Parsons, Frank G. Keller, et al.. (2024). Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma. JCO Oncology Practice. 21(4). 526–534. 3 indexed citations

Lo, Andrea, Amy Liu, Qi Liu, et al.. (2024). Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children. JAMA Network Open. 7(1). e2351062–e2351062. 8 indexed citations

Hoppe, Bradford S., Sharon M. Castellino, Qinglin Pei, et al.. (2023). Radiotherapy Utilization and Outcomes on a Contemporary Trial for Pediatric High-Risk Hodgkin Lymphoma Study. International Journal of Radiation Oncology*Biology*Physics. 117(2). S62–S63. 2 indexed citations

10.

Lo, Andrea, Inki Lee, Qinglin Pei, et al.. (2023). Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831. Pediatric Blood & Cancer. 70(8). e30452–e30452. 2 indexed citations

11.

Williams, AnnaLynn M., Angie Mae Rodday, Qinglin Pei, et al.. (2023). Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study. Blood. 142(Supplement 1). 672–672. 1 indexed citations

12.

Parsons, Susan K., Angie Mae Rodday, Qinglin Pei, et al.. (2023). Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study. Journal of Patient-Reported Outcomes. 7(1). 113–113. 9 indexed citations

13.

Friedman, Debra L., Kara M. Kelly, Qinglin Pei, et al.. (2020). LAG-3 is expressed on a majority of tumor infiltrating lymphocytes in pediatric Hodgkin lymphoma. Leukemia & lymphoma. 62(3). 606–613. 13 indexed citations

14.

Dvorak, Christopher C., Prakash Satwani, Elliot Stieglitz, et al.. (2018). Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Pediatric Blood & Cancer. 65(7). e27034–e27034. 23 indexed citations

15.

Cole, Peter D., Kathleen M. McCarten, Qinglin Pei, et al.. (2018). Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial. The Lancet Oncology. 19(9). 1229–1238. 54 indexed citations

16.

Kahn, Justine M., Kara M. Kelly, Qinglin Pei, et al.. (2017). Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials. Blood. 130. 607–607. 2 indexed citations

17.

Jia, Huanguang, Qinglin Pei, Diane Cowper Ripley, et al.. (2016). Poststroke Rehabilitation and Restorative Care Utilization. Medical Care. 54(3). 235–242. 6 indexed citations

18.

Nadeau, Stephen E., et al.. (2015). The Effects of Stroke Type, Locus, and Extent on Long-Term Outcome of Gait Rehabilitation. Neurorehabilitation and neural repair. 30(7). 615–625. 21 indexed citations

19.

Bega, Danny, Sam Wu, Qinglin Pei, Péter Schmidt, & Tanya Simuni. (2014). Recognition and Treatment of Depressive Symptoms in Parkinson's Disease: The NPF Dataset. Journal of Parkinson s Disease. 4(4). 639–643. 12 indexed citations

20.

Zuleger, Cindy, Michael D. Macklin, Bret L. Bostwick, et al.. (2010). In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells. Journal of Immunological Methods. 365(1-2). 76–86. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact